Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7332183 | CURRAX | Multilayer dosage forms containing NSAIDs and triptans |
Oct, 2025
(2 years from now) | |
US7332183
(Pediatric) | CURRAX | Multilayer dosage forms containing NSAIDs and triptans |
Apr, 2026
(3 years from now) |
Market Authorisation Date: 15 April, 2008
Treatment: Treatment of migraine; Acute treatment of migraine
Dosage: TABLET;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic